TransForm Pharmaceuticals Overview

  • Founded
  • 1999
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 80
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $230M
Latest Deal Amount

TransForm Pharmaceuticals General Information

Description

Developer of crystalline forms of drug molecules. The company engages in the clinical and commercial value of pharmaceutical products through optimization of physical form and formulation.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Primary Office
  • 29 Hartwell Avenue
  • Lexington, MA 02421
  • United States
+1 (781) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

TransForm Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Merger/Acquisition 03-May-2005 $230M 000.00 00000 Completed Startup
9. Later Stage VC (Series I) 16-Dec-2003 000 000.00 00000 Completed Startup
8. Later Stage VC (Series H) 24-Apr-2003 000.00 000.00 00000 Completed Startup
7. Later Stage VC (Series G) 18-Mar-2003 000 000.00 00000 Completed Startup
6. Later Stage VC (Series F) 28-Aug-2001 000.00 000.00 00000 Completed Startup
5. Later Stage VC (Series E) 27-Sep-2000 00.000 000.00 00000 Completed Startup
4. Later Stage VC (Series D) 19-Apr-2000 000.00 000.00 00000 Completed Startup
3. Later Stage VC (Series C) 000 000.00 000.00 Completed Startup
2. Early Stage VC (Series B) 30-Dec-1999 $1.1M $1.73M 00.000 Completed Startup
1. Early Stage VC (Series A) $635K $635K 00.000 Completed Startup
To view TransForm Pharmaceuticals’s complete valuation and funding history, request access »

TransForm Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series I 000,000 00.000000 00 000 000 00 000 0.000
Series H 0,000,000 00.000000 000 000 00 000 0.000
Series G 000,000 00.000000 000.0 000.0 00 000.0 0.000
Series F 000,000 00.000000 000 000 00 000 0.000
Series E 000,000 00.000000 000 000 00 000 0.00
Series D 0,000,000 00.000000 000 000 00 000 00.000
Series C 0,000,000 00.000000 00.0 00.0 00 00.0 00.000
Series B 2,300,000 $0.001000 $0.5 $0.5 1x $0.5 13.22%
Series A 1,270,000 $0.001000 $0.5 $0.5 1x $0.5 7.3%
To view TransForm Pharmaceuticals’s complete cap table history, request access »

TransForm Pharmaceuticals Executive Team (1)

Name Title Board Seat Contact Info
Norman Selby President and Chief Executive Officer
To view TransForm Pharmaceuticals’s complete executive team members history, request access »

TransForm Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TransForm Pharmaceuticals Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alexandria Venture Investments Corporate Venture Capital Minority 000 0000 000000 0
BB Bioventures Venture Capital Minority 000 0000 000000 0
HBM Healthcare Investments Venture Capital Minority 000 0000 000000 0
MPM Capital Venture Capital Minority 000 0000 000000 0
Novartis Venture Fund Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »